US Markets Closed

AI-assisted · Not financial adviceNot advice

AI-assisted · Not financial advice.

US Markets Closed

AI-assisted · Not financial adviceNot advice

US Markets Closed

AI-assisted · Not financial adviceNot advice

$UNH

Name: UNH (UnitedHealth) — Market Sentiment & Discussion
Creator: MarketMind
License: https://stockmarketsentimentai.com/methodology

UnitedHealth· 4/3/2026, 11:57:35 AM

Data Checks· 2 of 2 passed

Analyst target

39% upside · 14 analysts · $327–$444 range

▲ $385

Earnings

EPS: $17.85 → $19.82 (2026 vs 2027)

▲ Expected to grow 11%

Options positioning: Neutral — More betting on upside (2.2× more call than put volume today). Unusual bets on $285 upside — 1.3× normal activity. analysts: 41 buy vs 4 sell.

Reddit: CautiousAttention: Watching

Community Take (7D)

Retail bearish sentiment reflects reputation issues, while news maintains a moderate buy rating. This divergence suggests that while challenges exist, potential opportunities may arise.

News vs Reddit

Wait & See

News: divided · 60% qualityReddit: bearish · 40% confidence

The Story

News Summary

Analysts maintain moderate buy rating

Key Events

Mar 2, 2001:UnitedHealth Group Incorporated has earned an average rating of 'Moderate Buy' from analysts.
Feb 28, 2001:Andra AP fonden lessened its holdings in UnitedHealth Group by 48.1%.
Feb 25, 2001:UNH stock has dropped by 23.1% due to disappointing financial guidance.

Sentiment: 60% bullish / 40% neutral (early) → 70% bearish / 30% cautious (late)

Impact: Initially, analysts showed optimism with a moderate buy rating, but sentiment shifted negatively as stock performance declined significantly due to regulatory and financial concerns.

Risks: disappointing financial guidance, regulatory shocks

Analyst ConsensusBuy (52 analysts)

Target: $385 avg (+39% upside)

41 Buy · 7 Hold · 4 Sell

Signal

Divided

Confidence

60%

Based on curated news sources (not retail comments)

Over the last 7 days: While UnitedHealthcare's revenue growth is a positive sign, significant operating earnings decline and stock price drop due to regulatory concerns create a conflicting outlook.

SentimentNeutral

AnalysisHype

Bullish Factors

✓UnitedHealthcare's revenues climbed 15.7% in 2025 to $344.9 billion [Fmp|Feb 24]
✓Dakota Wealth Management boosted its stake in shares of UnitedHealth Group by 65.3% [Fmp|Feb 24]

Risk Factors

✗Adjusted operating earnings fell sharply by 41.1% to $9.6 billion due to reduced Medicare funding and elevated medical costs [Fmp|Feb 24]
✗UnitedHealth stock dropped by 23.1% in under a month due to disappointing financial guidance and proposed flat reimbursement rates for 2027 [Fmp|Feb 25]

Analyze with AI yahoo!finance Reddit Answers

AI-assisted · Not financial advice.

$UNH - UnitedHealth | MarketMind | MarketMind

$UNH

UnitedHealth· 4/3/2026, 11:57:35 AM

Data Checks· 2 of 2 passed

Analyst target

39% upside · 14 analysts · $327–$444 range

▲ $385

Earnings

EPS: $17.85 → $19.82 (2026 vs 2027)

▲ Expected to grow 11%

Options positioning: Neutral — More betting on upside (2.2× more call than put volume today). Unusual bets on $285 upside — 1.3× normal activity. analysts: 41 buy vs 4 sell.

Reddit: CautiousAttention: Watching

Community Take (7D)

Retail bearish sentiment reflects reputation issues, while news maintains a moderate buy rating. This divergence suggests that while challenges exist, potential opportunities may arise.

News vs Reddit

Wait & See

News: divided · 60% qualityReddit: bearish · 40% confidence

The Story

News Summary

Analysts maintain moderate buy rating

Key Events

Mar 2, 2001:UnitedHealth Group Incorporated has earned an average rating of 'Moderate Buy' from analysts.
Feb 28, 2001:Andra AP fonden lessened its holdings in UnitedHealth Group by 48.1%.
Feb 25, 2001:UNH stock has dropped by 23.1% due to disappointing financial guidance.

Sentiment: 60% bullish / 40% neutral (early) → 70% bearish / 30% cautious (late)

Impact: Initially, analysts showed optimism with a moderate buy rating, but sentiment shifted negatively as stock performance declined significantly due to regulatory and financial concerns.

Risks: disappointing financial guidance, regulatory shocks

Analyst ConsensusBuy (52 analysts)

Target: $385 avg (+39% upside)

41 Buy · 7 Hold · 4 Sell

Signal

Divided

Confidence

60%

Based on curated news sources (not retail comments)

Over the last 7 days: While UnitedHealthcare's revenue growth is a positive sign, significant operating earnings decline and stock price drop due to regulatory concerns create a conflicting outlook.

SentimentNeutral

AnalysisHype

Bullish Factors

✓UnitedHealthcare's revenues climbed 15.7% in 2025 to $344.9 billion [Fmp|Feb 24]
✓Dakota Wealth Management boosted its stake in shares of UnitedHealth Group by 65.3% [Fmp|Feb 24]

Risk Factors

✗Adjusted operating earnings fell sharply by 41.1% to $9.6 billion due to reduced Medicare funding and elevated medical costs [Fmp|Feb 24]
✗UnitedHealth stock dropped by 23.1% in under a month due to disappointing financial guidance and proposed flat reimbursement rates for 2027 [Fmp|Feb 25]

Analyze with AI yahoo!finance Reddit Answers